Últimas subidas - Macular Degeneration - Age Related, Myopic, Choroidal Neovascular Membranes
|
Staphyloma and Atrophy with Vitreoretinal tractionvista 35 vecesOnly eye of patient with Albinism and decreasing vision now 5/200 in this 72 year old man. There is myopic tractional maculopathy. The patient also has albinism by history.Abril 13, 2026
|
|
Staphyloma and Atrophy with Vitreoretinal tractionvista 32 vecesOnly eye of patient with Albinism and decreasing vision now 5/200 in this 72 year old man. There is myopic tractional maculopathy. The patient also has albinism by history.Abril 13, 2026
|
|
Staphyloma and Atrophy with Vitreoretinal tractionvista 33 vecesOnly eye of patient with Albinism and decreasing vision now 5/200 in this 72 year old man. There is myopic tractional maculopathy. The patient also has albinism by history.Abril 13, 2026
|
|
Conversion to Wet AMD after Izervayvista 36 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Conversion to Wet AMD after Izervayvista 40 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Conversion to Wet AMD after Izervayvista 34 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Conversion to Wet AMD after Izervayvista 48 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Conversion to Wet AMD after Izervayvista 39 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Conversion to Wet AMD after Izervayvista 31 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Conversion to Wet AMD after Izervayvista 41 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Conversion to Wet AMD after Izervayvista 36 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Conversion to Wet AMD after Izervayvista 42 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Conversion to Wet AMD after Izervayvista 35 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Conversion to Wet AMD after Izervayvista 37 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Conversion to Wet AMD after Izervayvista 33 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Conversion to Wet AMD after Izervayvista 44 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Conversion to Wet AMD after Izervayvista 37 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Conversion to Wet AMD after Izervayvista 33 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Conversion to Wet AMD after Izervayvista 35 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Conversion to Wet AMD after Izervayvista 38 veces83 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentMarzo 15, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 135 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 119 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 129 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 65 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 59 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 59 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 53 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 61 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 53 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 60 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 58 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 69 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 62 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 42 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 48 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 42 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 47 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 48 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 51 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 50 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 37 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 55 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 46 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 37 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 35 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvista 42 veces74 year old female with vision loss in eye with collapsed vitelliform lesion.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 60 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 35 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 43 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 42 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 29 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 35 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 43 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 46 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 38 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 36 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 33 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 26 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 37 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 29 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 35 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 40 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 35 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 35 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 43 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 47 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 38 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 39 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 39 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 42 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 43 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 27 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 44 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 40 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Peripapillary CNVM No Treatmentvista 37 veces85 year old with peripapillary CNVM watched for many years.Febrero 18, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 48 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 56 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 48 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 61 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 48 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 57 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 48 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 53 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 43 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 46 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 54 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 48 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 60 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 48 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 48 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 57 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 54 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vista 59 veces87 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400Enero 11, 2026
|
|
Stable Myopic Tractional Maculopathyvista 50 veces73 year old female with mild vision loss from table myopic tractional maculopathy in the left eyeNoviembre 23, 2025
|
|
Stable Myopic Tractional Maculopathyvista 43 veces73 year old female with mild vision loss from table myopic tractional maculopathy in the left eyeNoviembre 23, 2025
|
|
Stable Myopic Tractional Maculopathyvista 53 veces73 year old female with mild vision loss from table myopic tractional maculopathy in the left eyeNoviembre 23, 2025
|
|
Stable Myopic Tractional Maculopathyvista 44 veces73 year old female with mild vision loss from table myopic tractional maculopathy in the left eyeNoviembre 23, 2025
|
|
Stable Myopic Tractional Maculopathyvista 48 veces73 year old female with mild vision loss from table myopic tractional maculopathy in the left eyeNoviembre 23, 2025
|
|
Stable Myopic Tractional Maculopathyvista 50 veces73 year old female with mild vision loss from table myopic tractional maculopathy in the left eyeNoviembre 23, 2025
|
|
Stable Myopic Tractional Maculopathyvista 40 veces73 year old female with mild vision loss from table myopic tractional maculopathy in the left eyeNoviembre 23, 2025
|
|
| 2694 archivos en 27 página(s) |
1 |
 |
|
|
|
|
|
|
|
|
|
